Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × NETWORK × Receptors, Fc × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cisplatin 14 Paclitaxel 12 Cyclophosphamide 9 Taxes 8 Carboplatin 8 Platinum 6 Gemcitabine 6 1,2-diaminocyclohexaneplatinum II citrate 6 Trastuzumab 5 Radiotherapy 5 Oxaliplatin 5 Doxorubicin 5 Cytarabine 5 Capecitabine 5 Brachytherapy 5 fludarabine 4 Rituximab 4 Radiotherapy, Intensity-Modulated 4 Fluorouracil 4 Docetaxel 4 Watchful Waiting 3 Radiosurgery 3 Pemetrexed 3 Nimorazole 3 Imatinib Mesylate 3 Idarubicin 3 Gene Expression Profiling 3 thymoglobulin 2 regorafenib 2 pertuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02156726 2014-06-05

Q-lite

Czech CLL Study Group

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡